drugset / Trial / NCT00298610
Safety and Efficacy Study of IV Artesunate to Treat Malaria
Phase 2
Completed
30 enrolled
U.S. Army Medical Research and Development Command
Military Infectious Diseases Research Program (MIDRP) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine how GMP IV Artesunate is metabolized and cleared by individuals with uncomplicated malaria infection and to determine how fast it eliminates malaria infection from the body.
Timeline
- Start
- 2006-03
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | 2.4 mg/kg | Intravenous |
| Background | CYCLOGUANIL | Small molecule | — | — |